Double maintains 1 strategies that include RGNX - REGENXBIO, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 56.67% | $2.00B | -32.81% | 0.00% |
RCKT | 56.64% | $700.30M | -71.26% | 0.00% |
ARWR | 54.60% | $2.17B | -36.58% | 0.00% |
BEAM | 53.74% | $1.80B | -27.34% | 0.00% |
NTLA | 53.39% | $880.46M | -67.58% | 0.00% |
ALEC | 51.36% | $121.99M | -77.57% | 0.00% |
KYMR | 50.97% | $1.97B | -13.45% | 0.00% |
SYRE | 50.39% | $916.17M | -59.84% | 0.00% |
XNCR | 49.80% | $573.64M | -65.00% | 0.00% |
CMPS | 49.71% | $369.54M | -49.23% | 0.00% |
ACLX | 48.86% | $3.24B | +9.62% | 0.00% |
OC | 48.78% | $12.34B | -17.76% | 1.81% |
VYGR | 48.48% | $182.61M | -60.85% | 0.00% |
EYPT | 48.17% | $421.82M | -48.23% | 0.00% |
ATXS | 48.12% | $223.48M | -58.49% | 0.00% |
CRSP | 47.76% | $3.35B | -31.04% | 0.00% |
SITE | 47.54% | $5.62B | -17.46% | 0.00% |
ABCL | 47.40% | $605.92M | -44.23% | 0.00% |
KOD | 47.28% | $184.67M | +6.06% | 0.00% |
MGTX | 47.27% | $401.02M | -12.61% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VZ | -0.06% | $185.47B | +9.81% | 6.11% |
AWK | 0.27% | $27.80B | +6.58% | 2.19% |
CAG | 0.43% | $10.97B | -25.22% | 6.10% |
MSIF | 0.44% | $740.71M | +32.99% | 6.83% |
MDLZ | -0.49% | $84.58B | -8.30% | 2.81% |
GIS | 0.49% | $30.19B | -22.61% | 4.37% |
CPB | -0.86% | $10.59B | -23.55% | 4.27% |
ZCMD | 0.86% | $32.45M | -14.90% | 0.00% |
GFI | 1.00% | $18.47B | +26.47% | 2.64% |
CYCN | -1.01% | $9.76M | +6.67% | 0.00% |
NEUE | 1.24% | $61.51M | +15.03% | 0.00% |
TMUS | -1.44% | $275.53B | +47.96% | 1.26% |
STG | 1.48% | $24.93M | -43.62% | 0.00% |
PGR | -1.61% | $167.68B | +36.71% | 1.71% |
AEP | -1.62% | $55.04B | +11.19% | 3.56% |
FIZZ | 1.78% | $4.20B | +2.58% | 0.00% |
TPB | -1.87% | $1.32B | +117.00% | 0.39% |
YOU | 1.96% | $2.29B | +43.97% | 1.82% |
VSTA | -2.16% | $326.02M | +12.60% | 0.00% |
PG | -2.17% | $382.82B | -2.60% | 2.49% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -42.42% | $361.71M | 1.43% |
VIXY | -36.05% | $116.60M | 0.85% |
TAIL | -30.77% | $140.64M | 0.59% |
IVOL | -17.65% | $353.50M | 1.02% |
USDU | -8.83% | $173.33M | 0.5% |
BILS | -7.50% | $3.95B | 0.1356% |
BIL | -6.99% | $45.46B | 0.1356% |
FTSD | -6.79% | $212.61M | 0.25% |
XHLF | -5.58% | $1.46B | 0.03% |
CTA | -5.03% | $1.06B | 0.76% |
GBIL | -5.00% | $6.16B | 0.12% |
CLIP | -4.24% | $1.51B | 0.07% |
FXY | -4.16% | $850.17M | 0.4% |
SHYM | -3.98% | $323.00M | 0.35% |
SCHO | -3.78% | $10.84B | 0.03% |
UUP | -3.67% | $279.52M | 0.77% |
TFLO | -3.31% | $7.02B | 0.15% |
UNG | -3.25% | $335.18M | 1.06% |
KCCA | -2.97% | $95.62M | 0.87% |
ULST | -2.80% | $632.05M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 63.83% | $39.83M | 0.5% |
XBI | 61.78% | $4.85B | 0.35% |
IBB | 58.80% | $5.17B | 0.45% |
ARKG | 57.00% | $914.43M | 0.75% |
IWC | 56.79% | $772.99M | 0.6% |
PBE | 53.28% | $215.67M | 0.58% |
IWM | 53.18% | $63.66B | 0.19% |
VTWO | 53.11% | $12.07B | 0.07% |
KJAN | 53.11% | $304.58M | 0.79% |
IWO | 53.02% | $11.31B | 0.24% |
SCHA | 52.00% | $16.85B | 0.04% |
KJUL | 51.86% | $113.06M | 0.79% |
IWN | 51.75% | $11.00B | 0.24% |
CPRJ | 51.64% | $48.36M | 0.69% |
FBT | 51.40% | $1.00B | 0.56% |
BBH | 51.32% | $326.56M | 0.35% |
GSSC | 51.30% | $536.87M | 0.2% |
NUSC | 50.86% | $1.14B | 0.31% |
ESML | 50.76% | $1.80B | 0.17% |
PRFZ | 50.70% | $2.33B | 0.34% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VGSH | 0.01% | $22.36B | 0.03% |
GSST | 0.20% | $873.92M | 0.16% |
AGZD | -0.41% | $109.53M | 0.23% |
WEAT | -0.61% | $118.73M | 0.28% |
FXE | 1.14% | $516.25M | 0.4% |
DBE | 1.19% | $46.44M | 0.77% |
VTIP | 1.20% | $14.75B | 0.03% |
TBIL | 1.28% | $5.77B | 0.15% |
SHV | 1.30% | $20.91B | 0.15% |
IBTG | 1.58% | $1.89B | 0.07% |
STPZ | 1.61% | $452.72M | 0.2% |
TBLL | -1.62% | $2.38B | 0.08% |
AGZ | 1.68% | $608.43M | 0.2% |
BILZ | -1.70% | $901.37M | 0.14% |
XONE | -1.74% | $608.48M | 0.03% |
IBTH | 1.98% | $1.53B | 0.07% |
UGA | 2.09% | $72.41M | 0.97% |
IBMN | -2.44% | $444.85M | 0.18% |
LDUR | 2.45% | $850.25M | 0.5% |
TPMN | -2.49% | $31.59M | 0.65% |
Yahoo
REGENXBIO Inc. ( NASDAQ:RGNX ) just released its latest first-quarter report and things are not looking great. It looks...
Yahoo
NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) announced today that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) submission by REGENXBIO Inc. (REGENXBIO; Headquarters: Rockville, Maryland, USA; CEO: Curran M. Simpson, NASDAQ: RGNX) for RGX-121 (clemidsogene lanparvovec), a potential first-in-class, investigational gene therapy for the treatment of Mucopolysaccharidosis II (MPS II). The FDA granted
Yahoo
Q1 2025 Regenxbio Inc Earnings Call
Yahoo
REGENXBIO Inc. (Nasdaq: RGNX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) seeking accelerated approval for clemidsogene lanparvovec (RGX-121) for the treatment of Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome.
Finnhub
Regenxbio Inc: * REGENXBIO ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OFTHEBLA FOR RGX-121 FOR MPS II * REGENXBIO INC - FDA GRANTS PRIORITY REVIEW FOR...
Yahoo
Regenxbio Inc (RGNX) reports robust financial health and strategic advancements, with a focus on potential FDA approvals and commercial readiness.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -13.43% | $46.74M | -99.95% | 0.00% |
CBOE | -13.31% | $23.14B | +20.40% | 1.10% |
MO | -9.82% | $99.20B | +27.80% | 6.83% |
VHC | -9.70% | $35.69M | +82.65% | 0.00% |
NOC | -9.35% | $68.10B | +0.63% | 1.75% |
CHD | -9.26% | $23.60B | -9.94% | 1.21% |
KMB | -9.17% | $46.15B | +3.56% | 3.49% |
PPC | -7.48% | $11.53B | +46.93% | 0.00% |
KR | -7.40% | $45.50B | +27.03% | 1.85% |
MNOV | -6.64% | $64.74M | -7.04% | 0.00% |
CL | -6.12% | $73.93B | -3.08% | 2.22% |
LITB | -6.00% | $21.74M | -71.95% | 0.00% |
CME | -5.35% | $99.56B | +29.63% | 3.78% |
K | -4.71% | $28.55B | +33.69% | 2.75% |
ED | -4.29% | $37.58B | +7.40% | 3.21% |
BTCT | -4.13% | $25.93M | +92.53% | 0.00% |
EXC | -4.06% | $44.51B | +14.28% | 3.55% |
DUK | -3.64% | $90.36B | +11.91% | 4.48% |
SO | -3.43% | $97.50B | +11.53% | 3.26% |
KO | -3.30% | $309.91B | +14.23% | 2.73% |
Current Value
$8.661 Year Return
Current Value
$8.661 Year Return